A scientist works at Zai Lab's drug development facility in Shanghai, China October 18, 2017. To match Insight CHINA-BIOTECH/ REUTERS/Adam Jourdan
A scientist works at Zai Lab's drug development facility in Shanghai, China October 18, 2017. To match Insight CHINA-BIOTECH/ REUTERS/Adam Jourdan
IPO

Biotech firms the latest to respond to serenade by city’s bourse to raise capital in Hong Kong

Several biotech companies have contacted Hong Kong professional firms to check on the chance to list in Hong Kong

A scientist works at Zai Lab's drug development facility in Shanghai, China October 18, 2017. To match Insight CHINA-BIOTECH/ REUTERS/Adam Jourdan
A scientist works at Zai Lab's drug development facility in Shanghai, China October 18, 2017. To match Insight CHINA-BIOTECH/ REUTERS/Adam Jourdan
READ FULL ARTICLE